Stockreport

Alkermes Announces Completion of Patient Enrollment in Pivotal Antipsychotic Efficacy Study of ALKS 3831 for Schizophrenia

Alkermes plc - Ordinary Shares  (ALKS) 
Last alkermes plc - ordinary shares earnings: 4/29 07:00 am Check Earnings Report
PDF –– Topline Results From ENLIGHTEN-1 Study Expected Mid-2017 –– DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NASDAQ: ALKS) today announced completio [Read more]